Share on StockTwits

Investment analysts at Jefferies Group started coverage on shares of Trevena (NASDAQ:TRVN) in a note issued to investors on Wednesday, reports. The firm set a “buy” rating and a $11.00 price target on the stock. Jefferies Group’s price target indicates a potential upside of 41.57% from the stock’s previous close.

Trevena, Inc (NASDAQ:TRVN) is a clinical stage biopharmaceutical company.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.